Updated Press Release: An earlier version of this announcement was inadvertently distributed in error. This release supersedes all prior versions and reflects the Company's accurate and complete disclosure. VitaSmart Commercial Launch Expected 1Q26 FDA-cleared labeling supports broad...
Bridge to LifeTM Secures FDA De Novo Clearance for VitaSmartTM Hypothermic Oxygenated Perfusion (HOPE) System, the First Ever U.S. Approval for Cold Machine Perfusion in Liver Transplant Preservation